共查询到20条相似文献，搜索用时 15 毫秒
1.
The accuracy (sensitivity and specificity) of a new screening test can be compared with that of a standard test by applying both tests to a group of subjects in which disease status can be determined by a gold standard (GS) test. However, it is not always feasible to administer a GS test to all study subjects. For example, a study is planned to determine whether a new screening test for cervical cancer (\"ThinPrep\") is better than the standard test (\"Pap\"), and in this setting it is not feasible (or ethical) to determine disease status by biopsy in order to identify women with and without disease for participation in a study. When determination of disease status is not possible for all study subjects, the relative accuracy of two screening tests can still be estimated by using a paired screen-positive (PSP) design in which all subjects receive both screening tests, but only have the GS test if one of the screening tests is positive. Unfortunately in the cervical cancer example, the PSP design is also infeasible because it is not technically possible to administer both the ThinPrep and Pap at the same time. In this article, we describe a randomized paired screen-positive (RPSP) design in which subjects are randomized to receive one of the two screening tests initially, and only receive the other screening test and GS if the first screening test is positive. We derive maximum likelihood estimators and confidence intervals for the relative accuracy of the two screening tests, and assess the small sample behavior of these estimators using simulation studies. Sample size formulae are derived and applied to the cervical cancer screening trial example, and the efficiency of the RPSP design is compared with other designs. 相似文献
2.
Ying Zhang Todd A. Alonzo for the Alzheimer's Disease Neuroimaging Initiative 《Biometrical journal. Biometrische Zeitschrift》2016,58(6):1338-1356
In diagnostic medicine, the volume under the receiver operating characteristic (ROC) surface (VUS) is a commonly used index to quantify the ability of a continuous diagnostic test to discriminate between three disease states. In practice, verification of the true disease status may be performed only for a subset of subjects under study since the verification procedure is invasive, risky, or expensive. The selection for disease examination might depend on the results of the diagnostic test and other clinical characteristics of the patients, which in turn can cause bias in estimates of the VUS. This bias is referred to as verification bias. Existing verification bias correction in three‐way ROC analysis focuses on ordinal tests. We propose verification bias‐correction methods to construct ROC surface and estimate the VUS for a continuous diagnostic test, based on inverse probability weighting. By applying U‐statistics theory, we develop asymptotic properties for the estimator. A Jackknife estimator of variance is also derived. Extensive simulation studies are performed to evaluate the performance of the new estimators in terms of bias correction and variance. The proposed methods are used to assess the ability of a biomarker to accurately identify stages of Alzheimer's disease. 相似文献
3.
We develop a Bayesian simulation based approach for determining the sample size required for estimating a binomial probability and the difference between two binomial probabilities where we allow for dependence between two fallible diagnostic procedures. Examples include estimating the prevalence of disease in a single population based on results from two imperfect diagnostic tests applied to sampled individuals, or surveys designed to compare the prevalences of two populations using diagnostic outcomes that are subject to misclassification. We propose a two stage procedure in which the tests are initially assumed to be independent conditional on true disease status (i.e. conditionally independent). An interval based sample size determination scheme is performed under this assumption and data are collected and used to test the conditional independence assumption. If the data reveal the diagnostic tests to be conditionally dependent, structure is added to the model to account for dependence and the sample size routine is repeated in order to properly satisfy the criterion under the correct model. We also examine the impact on required sample size when adding an extra heterogeneous population to a study. 相似文献
4.
Disease prevalence is ideally estimated using a 'gold standard' to ascertain true disease status on all subjects in a population of interest. In practice, however, the gold standard may be too costly or invasive to be applied to all subjects, in which case a two-phase design is often employed. Phase 1 data consisting of inexpensive and non-invasive screening tests on all study subjects are used to determine the subjects that receive the gold standard in the second phase. Naive estimates of prevalence in two-phase studies can be biased (verification bias). Imputation and re-weighting estimators are often used to avoid this bias. We contrast the forms and attributes of the various prevalence estimators. Distribution theory and simulation studies are used to investigate their bias and efficiency. We conclude that the semiparametric efficient approach is the preferred method for prevalence estimation in two-phase studies. It is more robust and comparable in its efficiency to imputation and other re-weighting estimators. It is also easy to implement. We use this approach to examine the prevalence of depression in adolescents with data from the Great Smoky Mountain Study. 相似文献
5.
Changyu Shen Xiaochun Li Lingling Li Martin C. Were 《Biometrical journal. Biometrische Zeitschrift》2011,53(5):822-837
Evaluation of impact of potential uncontrolled confounding is an important component for causal inference based on observational studies. In this article, we introduce a general framework of sensitivity analysis that is based on inverse probability weighting. We propose a general methodology that allows both non‐parametric and parametric analyses, which are driven by two parameters that govern the magnitude of the variation of the multiplicative errors of the propensity score and their correlations with the potential outcomes. We also introduce a specific parametric model that offers a mechanistic view on how the uncontrolled confounding may bias the inference through these parameters. Our method can be readily applied to both binary and continuous outcomes and depends on the covariates only through the propensity score that can be estimated by any parametric or non‐parametric method. We illustrate our method with two medical data sets. 相似文献
6.
Prospective studies of diagnostic test accuracy have important advantages over retrospective designs. Yet, when the disease being detected by the diagnostic test(s) has a low prevalence rate, a prospective design can require an enormous sample of patients. We consider two strategies to reduce the costs of prospective studies of binary diagnostic tests: stratification and two-phase sampling. Utilizing neither, one, or both of these strategies provides us with four study design options: (1) the conventional design involving a simple random sample (SRS) of patients from the clinical population; (2) a stratified design where patients from higher-prevalence subpopulations are more heavily sampled; (3) a simple two-phase design using a SRS in the first phase and selection for the second phase based on the test results from the first; and (4) a two-phase design with stratification in the first phase. We describe estimators for sensitivity and specificity and their variances for each design, along with sample size estimation. We offer some recommendations for choosing among the various designs. We illustrate the study designs with two examples. 相似文献
7.
Planning studies involving diagnostic tests is complicated by the fact that virtually no test provides perfectly accurate results. The misclassification induced by imperfect sensitivities and specificities of diagnostic tests must be taken into account, whether the primary goal of the study is to estimate the prevalence of a disease in a population or to investigate the properties of a new diagnostic test. Previous work on sample size requirements for estimating the prevalence of disease in the case of a single imperfect test showed very large discrepancies in size when compared to methods that assume a perfect test. In this article we extend these methods to include two conditionally independent imperfect tests, and apply several different criteria for Bayesian sample size determination to the design of such studies. We consider both disease prevalence studies and studies designed to estimate the sensitivity and specificity of diagnostic tests. As the problem is typically nonidentifiable, we investigate the limits on the accuracy of parameter estimation as the sample size approaches infinity. Through two examples from infectious diseases, we illustrate the changes in sample sizes that arise when two tests are applied to individuals in a study rather than a single test. Although smaller sample sizes are often found in the two-test situation, they can still be prohibitively large unless accurate information is available about the sensitivities and specificities of the tests being used. 相似文献
8.
Sensitivity and specificity are common measures used to evaluate the performance of a diagnostic test. A diagnostic test is often administrated at a subunit level, e.g. at the level of vessel, ear or eye of a patient so that the treatment can be targeted at the specific subunit. Therefore, it is essential to evaluate the diagnostic test at the subunit level. Often patients with more negative subunit test results are less likely to receive the gold standard tests than patients with more positive subunit test results. To account for this type of missing data and correlation between subunit test results, we proposed a weighted generalized estimating equations (WGEE) approach to evaluate subunit sensitivities and specificities. A simulation study was conducted to evaluate the performance of the WGEE estimators and the weighted least squares (WLS) estimators (Barnhart and Kosinski, 2003) under a missing at random assumption. The results suggested that WGEE estimator is consistent under various scenarios of percentage of missing data and sample size, while the WLS approach could yield biased estimators due to a misspecified missing data mechanism. We illustrate the methodology with a cardiology example. 相似文献
9.
Linbo Wang Eric Tchetgen Tchetgen Torben Martinussen Stijn Vansteelandt 《Biometrics》2023,79(2):564-568
In this paper, we respond to comments on our paper, “Instrumental variable estimation of the causal hazard ratio.” 相似文献
10.
11.
Rotnitzky, Robins, and Scharfstein (1998, Journal of the American Statistical Association 93, 1321-1339) developed a methodology for conducting sensitivity analysis of studies in which longitudinal outcome data are subject to potentially nonignorable missingness. In their approach, they specify a class of fully parametric selection models, indexed by a non- or weakly identified selection bias function that indicates the degree to which missingness depends on potentially unobservable outcomes. Estimation of the parameters of interest proceeds by varying the selection bias function over a range considered plausible by subject-matter experts. In this article, we focus on cross-sectional, univariate outcome data and extend their approach to a class of semiparametric selection models, using generalized additive restrictions. We propose a backfitting algorithm to estimate the parameters of the generalized additive selection model. For estimation of the mean outcome, we propose three types of estimating functions: simple inverse weighted, doubly robust, and orthogonal. We present the results of a data analysis and a simulation study. 相似文献
12.
13.
Summary . We develop sample size formulas for studies aiming to test mean differences between a treatment and control group when all-or-none nonadherence (noncompliance) and selection bias are expected. Recent work by Fay, Halloran, and Follmann (2007, Biometrics 63, 465–474) addressed the increased variances within groups defined by treatment assignment when nonadherence occurs, compared to the scenario of full adherence, under the assumption of no selection bias. In this article, we extend the authors' approach to allow selection bias in the form of systematic differences in means and variances among latent adherence subgroups. We illustrate the approach by performing sample size calculations to plan clinical trials with and without pilot adherence data. Sample size formulas and tests for normally distributed outcomes are also developed in a Web Appendix that account for uncertainty of estimates from external or internal pilot data. 相似文献
14.
Ghosh D 《Biometrics》2008,64(1):141-148
Summary. There has been some recent work in the statistical literature for modeling the relationship between the size of cancers and probability of detecting metastasis, i.e., aggressive disease. Methods for assessing covariate effects in these studies are limited. In this article, we formulate the problem as assessing covariate effects on a right-censored variable subject to two types of sampling bias. The first is the length-biased sampling that is inherent in screening studies; the second is the two-phase design in which a fraction of tumors are measured. We construct estimation procedures for the proportional hazards model that account for these two sampling issues. In addition, a Nelson–Aalen type estimator is proposed as a summary statistic. Asymptotic results for the regression methodology are provided. The methods are illustrated by application to data from an observational cancer study as well as to simulated data. 相似文献
15.
Albert PS 《Biometrics》2007,63(3):947-957
Interest often focuses on estimating sensitivity and specificity of a group of raters or a set of new diagnostic tests in situations in which gold standard evaluation is expensive or invasive. Various authors have proposed semilatent class modeling approaches for estimating diagnostic accuracy in this situation. This article presents imputation approaches for this problem. I show how imputation provides a simpler way of performing diagnostic accuracy and prevalence estimation than the use of semilatent modeling. Furthermore, the imputation approach is more robust to modeling assumptions and, in general, there is only a moderate efficiency loss relative to a correctly specified semilatent class model. I apply imputation to a study designed to estimate the diagnostic accuracy of digital radiography for gastric cancer. The feasibility and robustness of imputation is illustrated with analysis, asymptotic results, and simulations. 相似文献
16.
17.
Summary . Analysis of instrument reliability and rater agreement is used in a wide range of behavioral, medical, psychosocial, and health-care-related research to assess psychometric properties of instruments, consensus in disease diagnoses, fidelity of psychosocial intervention, and accuracy of proxy outcomes. For categorical outcomes, Cohen's kappa is the most widely used index of agreement and reliability. In many modern-day applications, data are often clustered, making inference difficult to perform using existing methods. In addition, as longitudinal study designs become increasingly popular, missing data have become a serious issue, and the lack of methods to systematically address this problem has hampered the progress of research in the aforementioned fields. In this article, we develop a novel approach based on a new class of kappa estimates to tackle the complexities involved in addressing missing data and other related issues arising from a general multirater and longitudinal data setting. The approach is illustrated with real data in sexual health research. 相似文献
18.
目的:分析和评价Ranson、Glasgow、APACHEⅡ和BISAP 4种临床评分标准对急性胰腺炎严重程度的评估价值。方法:回顾性研究急性胰腺炎患者225例,分别应用APACHEⅡ、Ranson、Glasgow及BISAP评分标准对急性胰腺炎患者进行评分,比较分析不同评分标准对该类患者诊断的敏感性、特异性,以及对合并脏器功能不全的预测情况。结果:225例患者中,轻型胰腺炎188例,重型胰腺炎37例,在轻型和重型胰腺炎患者中,4种评分标准分值差异均有统计学意义(P0.01)。47例患者存在器官功能不全,4种评分标准与患者合并脏器功能不全均显著相关。各评分标准中,APACHEⅡ对急性重症胰腺炎评估的敏感性、特异性最好,分别为76%和72%。结论:4中评分方法各有特点,综合应用可能更准确的评估疾病严重程度及预后。 相似文献
19.
摘要目的：建立同时实现乙型肝炎病毒(hepatitis B virus,HBV)、丙型肝炎病毒(hepatitis C virus,HCV)、艾滋病病毒(humanImmunodeficiency Virus,HIV)检测的多重核酸筛查系统。方法：以HBV、HCV、HIV 的保守序列为模板设计特异性引物和探针,通过核酸自动提取系统结合一步法RT-PCR技术平台,优化相关反应体系和条件,建立多重多色实时荧光PCR检测血源性传播病毒的核酸筛查系统。将该系统用于101387 例血浆样本的筛查。结果：本研究建立的核酸筛查系统特异性好,HBV灵敏度可以达到20IU/ml,HCV 灵敏度可以达到100IU/ml,HIV 灵敏度可以达到50IU/mL。结论：本研究建立的核酸筛查系统具有高度自动化、高灵敏度、低成本等特点,适合我国血站系统推广使用。 相似文献
20.
Inference on treatment effects in a pretest-posttest study is a routine objective in medicine, public health, and other fields. A number of approaches have been advocated. We take a semiparametric perspective, making no assumptions about the distributions of baseline and posttest responses. By representing the situation in terms of counterfactual random variables, we exploit recent developments in the literature on missing data and causal inference, to derive the class of all consistent treatment effect estimators, identify the most efficient such estimator, and outline strategies for implementation of estimators that may improve on popular methods. We demonstrate the methods and their properties via simulation and by application to a data set from an HIV clinical trial. 相似文献